{"id":"https://openalex.org/W2057777779","doi":"https://doi.org/10.1001/jama.1955.02960160055016","title":"DESIGNATION OF \"TRANQUILIZING AGENTS\" IN NEUROPHARMACOLOGY","display_name":"DESIGNATION OF \"TRANQUILIZING AGENTS\" IN NEUROPHARMACOLOGY","publication_year":1955,"publication_date":"1955-08-20","ids":{"openalex":"https://openalex.org/W2057777779","doi":"https://doi.org/10.1001/jama.1955.02960160055016","mag":"2057777779"},"language":"en","primary_location":{"id":"doi:10.1001/jama.1955.02960160055016","doi":"https://doi.org/10.1001/jama.1955.02960160055016","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.1955.02960160055016","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Medical Association","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037107802","display_name":"Howard D. Fabing","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Howard D. Fabing","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5037107802"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9623,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.84947958,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"158","issue":"16","first_page":"1461","last_page":"1461"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.6054999828338623,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.6054999828338623,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12666","display_name":"Historical Psychiatry and Medical Practices","score":0.16300000250339508,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.08250000327825546,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.800000011920929},{"id":"https://openalex.org/keywords/chlorpromazine","display_name":"chlorpromazine","score":0.7850000262260437},{"id":"https://openalex.org/keywords/rauwolfia-alkaloids","display_name":"Rauwolfia alkaloids","score":0.9739999771118164},{"id":"https://openalex.org/keywords/lysergic-acid-diethylamide","display_name":"lysergic acid diethylamide","score":0.9100000262260437},{"id":"https://openalex.org/keywords/mescaline","display_name":"mescaline","score":0.9850000143051147},{"id":"https://openalex.org/keywords/hallucinogen-induced-psychosis","display_name":"hallucinogen-induced psychosis","score":0.8009999990463257},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9259999990463257},{"id":"https://openalex.org/keywords/psychiatric-nomenclature","display_name":"psychiatric terminology","score":0.5490000247955322}],"concepts":[{"id":"https://openalex.org/C128188215","wikidata":"https://www.wikidata.org/wiki/Q3026765","display_name":"Neuropharmacology","level":2,"score":0.9516809582710266},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.39774149656295776},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33284133672714233},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33142396807670593},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22878271341323853}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1001/jama.1955.02960160055016","doi":"https://doi.org/10.1001/jama.1955.02960160055016","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.1955.02960160055016","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the American Medical Association","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W361565718","https://openalex.org/W1486365742","https://openalex.org/W2033652018","https://openalex.org/W2410924575","https://openalex.org/W2083920990","https://openalex.org/W2003116544","https://openalex.org/W2474575287","https://openalex.org/W2048125027","https://openalex.org/W31834551","https://openalex.org/W2063818783"],"abstract_inverted_index":{"To":[0],"the":[1,38,105,137,144],"Editor:\u2014":[2],"An":[3],"already":[4],"overburdened":[5],"glossary":[6],"provokes":[7],"misgivings":[8],"in":[9,58,104,126],"anyone":[10],"who":[11],"proposes":[12],"to":[13,29],"coin":[14],"a":[15,27,53],"new":[16,23,45],"term.":[17],"There":[18],"are":[19,47],"occasions,":[20],"however,":[21],"when":[22],"experience":[24],"calls":[25],"for":[26],"word":[28],"encompass":[30],"it.":[31],"Recent":[32],"clinical":[33,128],"use":[34],"of":[35,49,52,56,75,109,130,133],"chlorpromazine":[36],"and":[37,63,91,107,121,140],"Rauwolfia":[39],"fractions":[40],"has":[41,79],"demonstrated":[42],"that":[43],"these":[44],"compounds":[46],"capable":[48],"producing":[50],"amelioration":[51],"wide":[54],"spectrum":[55],"symptoms":[57],"psychiatric":[59],"disorders":[60],"on":[61],"occasion":[62],"thus":[64],"\"normalizing\"":[65],"such":[66,116],"patients.":[67],"Recently":[68],"another":[69],"drug":[70],"having":[71],"limited":[72],"therapeutic":[73],"qualities":[74],"this":[76],"general":[77],"type":[78],"been":[80],"reported":[81],"by":[82,113],"me":[83],"(Science121:208":[84],"[Feb.":[85],"11]":[86],"1955,":[87],"andNeurology5:319":[88],"[May]":[89],"1955)":[90],"is":[92,102],"undergoing":[93],"further":[94],"study.":[95],"Alpha":[96],"(4-piperidyl)":[97],"benzhydrol":[98],"hydrochloride,":[99],"or":[100],"Frenquel,":[101],"effective":[103],"prevention":[106],"treatment":[108],"model":[110],"psychoses":[111],"produced":[112],"hallucinogenic":[114],"drugs":[115],"as":[117,123,125],"lysergic":[118],"acid":[119],"diethylamide":[120],"mescaline,":[122],"well":[124],"some":[127],"cases":[129],"dissociation":[131],"syndromes":[132],"schizophrenic":[134],"pattern.":[135],"Although":[136],"neurophysiological,":[138],"neurochemical,":[139],"neuropharmacological":[141],"mechanisms":[142],"behind":[143]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-08-19T15:00:24.278416","created_date":"2016-06-24T00:00:00"}